Minnesota prison inmates sue to gain access to costly hepatitis C medications

May 26, 2015
Two inmates are suing the ­Minnesota Department of Corrections, seeking access to costly drug treatments for hepatitis C. Breakthrough medicine for hepatitis C started being approved in the U.S. in late 2013, the lawsuit states, and has become the standard of care with a 95% cure rate. Yet the inmates have been denied access "in deliberate indifference to their serious medical needs," the lawsuit states. Filed in federal court this month, the lawsuit taps into a national debate over how prison systems can afford the costly new drugs, some of which carry a sticker price of $1,000 per pill and $90,000 for the full treatment.